Overview
ABT market data
Price History
ABT price chart · 1M
- O
- 103.52
- H
- 103.52
- L
- 101.69
- C
- 102.99
- Vol
- 309,266.00
Daily history from Jan 4, 2016
- Source
- US equities market feed
- Observed
- Cadence
- Five-minute page cache; daily and stored hourly bars
- Status
- fresh
Key Stats & Performance
- Open
- $103.52
- Previous Close
- $102.69
- Day High
- $103.52
- Day Low
- $101.69
- 52 Week High
- $130.33
- 52 Week Low
- $81.39
- 7 Day Return
- +4.33%
- 30 Day Return
- -0.09%
- 90 Day Return
- +4.25%
- 1 Year Return
- -20.95%
- Daily Notional Volume
- $31.9M Latest daily bar volume multiplied by its closing price.
Valuation & Profitability
- P/E (TTM)
- 32.20 Trailing twelve-month price-to-earnings ratio. Higher means the market is pricing in more growth. Negative or missing when earnings are negative.
- Forward P/E
- — P/E based on consensus forward EPS estimates. Lower versus trailing implies expected earnings growth.
- EPS (TTM)
- $3.73 Diluted earnings per share over the trailing twelve months.
- Beta
- 0.55 Volatility relative to the index. 1.00 equals market, above 1 amplifies the broad-market move, below 1 dampens it.
- Dividend Yield
- 2.0% Annual dividend per share divided by current price. Zero or blank when the company does not pay a dividend.
- Profit Margin
- 11.7% Net income divided by revenue. Comparable within a sector, less so across sectors.
- 52w range
- $81.97 – $135.13 Lowest and highest closing prices over the past 52 weeks.
- Analyst Target
- $120.20 Mean of sell-side analyst 12-month price targets. Use as a sentiment gauge; targets are biased upward in aggregate.
Display-only. Refreshed once per symbol per 24 hours · market cap $174.7B · P/B 4.18 · P/S 3.75.
Company News
10 captured
Global Microbiology Testing Market to Grow Rapidly at a CAGR of ~9% by 2034 | DelveInsightGlobenewswire Inc ·
Abbott Laboratories vs. Intuitive Surgical: Which Healthcare Stock Is a Better Buy in 2026?The Motley Fool ·
A Stock Market Crash Is Coming By the End of 2027, According to Some Economists. Here Are 2 Stocks to Buy Before That HappensThe Motley Fool ·
China Adult Feeding Tubes and Formula Market Outlook to 2033 - Revenue, Volume, Pricing, and Company Share | Forecast Data Reveals Market Entry and Expansion OpportunitiesGlobenewswire Inc ·
Is it the Right Time to Add Phibro Stock to Your Portfolio?Zacks Investment Research ·
This Generac Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For ThursdayBenzinga ·